Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1Disease 1Cardiovascular Diseases 1

Interventions

acalabrutinib 2Social Determinants of Health 2Electrocardiography 2Echocardiography 2Blood Specimen Collection 2Aspirin 2zanubrutinib 1ribociclib 1phosphoribosylformylglycinamidine synthetase 1palbociclib 1ibrutinib 1glycidol 1abemaciclib 1Vascular Stiffness 1Testosterone 1Pulse Wave Analysis 1Noninvasive Prenatal Testing 1Magnetic Resonance Spectroscopy 1Health Services Needs and Demand 1Gonadotropin-Releasing Hormone 1Genetic Testing 1Exercise 1Eating 1Diet 1DNA 1Chemoradiotherapy 1Cardiovascular Agents 1Antineoplastic Agents 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cardiovascular Diseases × glycidol × Clear all
NCT05930626 2023-07-05

Biomarkers of Acrylamide, Glycidol, POPs, PFAS and Disease Outcomes and OMICs Signatures

Karolinska Institutet

Completed
9,254 enrolled

Cardiovascular Diseases, Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡